HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Correction to: Efficacy of canakinumab as first-line biologic agent in adult-onset Still's disease.

Abstract
Following publication of the original article [1], the authors reported an error in the spelling of Lorenzo Dagna's name.
AuthorsGiulio Cavalli, Alessandro Tomelleri, Giacomo De Luca, Corrado Campochiaro, Charles A Dinarello, Elena Baldissera, Lorenzo Dagna
JournalArthritis research & therapy (Arthritis Res Ther) Vol. 21 Issue 1 Pg. 69 (Feb 25 2019) ISSN: 1478-6362 [Electronic] England
PMID30803447 (Publication Type: Published Erratum)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: